Tempest Therapeutics (TPST) Tax Provisions (2015 - 2025)
Tempest Therapeutics (TPST) posted Tax Provisions of $14000.0 for Q4 2024, up 100.23% sequentially from -$6.2 million in Q4 2023, and up 100.23% YoY from $6992.1 in Q1 2024.
Tempest Therapeutics (TPST) Tax Provisions (2015 - 2025) Analysis & Trends
Tempest Therapeutics has reported Tax Provisions for 6 years, with the latest figure at $14000.0 in Q4 2024.
- Quarterly Tax Provisions rose 100.23% year-over-year to $14000.0 in Q4 2024, while the trailing twelve-month figure through Sep 2025 was $14000.0 (up 100.23% YoY) and the FY2024 annual result came in at $14000.0, up 100.23% from the prior year.
- Tax Provisions grew to $14000.0 in Q4 2024 per TPST's latest filing, from -$6.2 million in the prior quarter.
- Over five years, Tax Provisions peaked at $14000.0 in Q4 2024 and troughed at -$6.2 million in Q4 2023.
- A 3-year average of -$3.4 million and a median of -$3.9 million in 2021 frame the typical range for Tax Provisions.
- The widest YoY moves for Tax Provisions: up 100.23% in 2024, down 100.23% in 2024.
- Over 3 years, Tax Provisions stood at -$3.9 million in 2021, then plunged by 59.3% to -$6.2 million in 2023, then jumped by 100.23% to $14000.0 in 2024.
- According to Business Quant data, Tax Provisions over the past three periods registered $14000.0, -$6.2 million, and -$3.9 million for Q4 2024, Q4 2023, and Q4 2021 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 292.00 Mn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 230.90 Mn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 59.00 Mn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 15.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 75.45 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 13.31 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 1.90 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -90.33 Mn |
| 10 | Tempest Therapeutics | 4.23 Mn | 3.43 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -5.51 Mn |
| Dec 31, 2024 | 14,000.00 |
| Dec 31, 2023 | -6.19 Mn |
| Dec 31, 2021 | -3.89 Mn |
| Dec 31, 2017 | 34,000.00 |
| Sep 30, 2017 | 11,000.00 |
| Jun 30, 2017 | 13,000.00 |
| Mar 31, 2017 | 9,000.00 |
| Dec 31, 2016 | -16,000.00 |
| Sep 30, 2016 | 92,000.00 |
| Jun 30, 2016 | 50,000.00 |
| Mar 31, 2016 | 75,000.00 |
| Dec 31, 2015 | 75,000.00 |